Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study. (Record no. 26701568)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02438 a2200697 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517131154.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201803s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1557-3265 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/1078-0432.CCR-16-1729 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Connolly, Roisin M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180316 |
245 00 - TITLE STATEMENT | |
Title | Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
Date of publication, distribution, etc. | Jun 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2691-2701 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Azacitidine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Combined Modality Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epigenesis, Genetic |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Estrogen Receptor alpha |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | National Cancer Institute (U.S.) |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triple Negative Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Huili |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jankowitz, Rachel C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhang, Zhe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rudek, Michelle A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jeter, Stacie C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Slater, Shannon A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Powers, Penny |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wolff, Antonio C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fetting, John H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brufsky, Adam |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Piekarz, Richard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ahuja, Nita |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Laird, Peter W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shen, Hui |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Weisenberger, Daniel J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cope, Leslie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Herman, James G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Somlo, George |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Garcia, Agustin A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jones, Peter A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Baylin, Stephen B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Davidson, Nancy E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zahnow, Cynthia A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stearns, Vered |
773 0# - HOST ITEM ENTRY | |
Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
Related parts | vol. 23 |
-- | no. 11 |
-- | p. 2691-2701 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-16-1729">https://doi.org/10.1158/1078-0432.CCR-16-1729</a> |
Public note | Available from publisher's website |
No items available.